Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients

OBJECTIVE: To evaluate the long-term safety, tolerability, and efficacy of colesevelam HCl (colesevelam) in type 2 diabetes mellitus patients receiving metformin monotherapy or metformin combination therapy. METHODS: This post-hoc subgroup analysis examined data from type 2 diabetes mellitus patient...

Descripción completa

Detalles Bibliográficos
Autor principal: Bays, Harold E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395894/
https://www.ncbi.nlm.nih.gov/pubmed/22807633
http://dx.doi.org/10.2147/DMSO.S32018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395894/
https://www.ncbi.nlm.nih.gov/pubmed/22807633
http://dx.doi.org/10.2147/DMSO.S32018

Ejemplares similares